SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer

Thorsten Schaefer1, Rebekah Steiner2, Claudia Lengerke1,3

  • 1Stem Cells & Hematopoiesis Laboratory, Department of Biomedicine, University of Basel and University Hospital Basel, CH-4031 Basel, Switzerland.

Insights

Stemness relies on SOX2 regulation by the PI3K/AKT pathway, which also impacts DNA damage response via p53. This balance is crucial for stem cell function and cancer development.

Area of Science:

  • Stem cell biology
  • Molecular oncology
  • Signaling pathways

Background:

  • Stemness, characterized by self-renewal and suppressed differentiation, is regulated by master transcription factors like SOX2.
  • The PI3K/AKT signaling pathway plays a critical role in stem cell maintenance, influencing SOX2 localization and turnover.
  • Apoptosis, a key component of DNA damage response (DDR), is regulated by tumor suppressor p53 and counteracted by PI3K/AKT signaling.

Purpose of the Study:

  • To review the interplay between PI3K/AKT/SOX2-driven stemness and p53-mediated DDR.
  • To highlight the significance of these pathways in pluripotency, cellular reprogramming, and cancer development.
  • To summarize recent advances in understanding these molecular mechanisms.

Main Methods:

  • Literature review of studies on stemness, SOX2, PI3K/AKT signaling, p53, and DNA damage response.
  • Analysis of molecular mechanisms connecting these pathways in various cell types (ESCs, iPSCs, CSCs).
  • Focus on the functional overlap and implications in genomic integrity and transformation.

Main Results:

  • The PI3K/AKT/SOX2 axis is a stem cell-specific pathway regulating SOX2, cell cycle, growth, and apoptosis.
  • SOX2 expression and p53-dependent DDR mechanisms share molecular-functional links within PI3K/AKT signaling.
  • Genomic instability in stem cells, potentially exacerbated by reprogramming (iPSCs), can lead to cancer.

Conclusions:

  • The intricate relationship between stemness regulators (SOX2) and DNA damage response (p53) via PI3K/AKT signaling is vital for stem cell homeostasis.
  • Dysregulation of this balance poses risks for genomic integrity, contributing to cancer initiation and progression.
  • Understanding these pathways offers insights into stem cell biology, reprogramming, and therapeutic strategies for cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K